The tumor microenvironment represents a unique system for intercellular metabolic interactions, where tumor‐derived metabolites suppress effector CD8+ T cells and promote tumor‐promoting macrophages, reinforcing an immune‐suppressive niche. The gene discussed is CD8A; the disease is neoplasm.